Dr. Osinusi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Baltimore, MD 21201Phone+1 410-706-4613Fax+1 410-706-4619
Education & Training
- University of MarylandFellowship, Infectious Disease, 2008 - 2010
- Rush University Medical CenterResidency, Internal Medicine, 2004 - 2007
- University of IbadanClass of 2000
Certifications & Licensure
- CA State Medical License 2019 - 2025
- DC State Medical License 2010 - 2024
- MD State Medical License 2010 - 2015
- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 243 citationsSofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.A. Osinusi, Eric G. Meissner, Yu-Jin Lee, Dimitra Bon, Laura Heytens
JAMA. 2013-08-28 - 121 citationsVirological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort studyAnita Kohli, A. Osinusi, Zayani Sims, Amy Nelson, Eric G. Meissner
Lancet. 2015-03-21 - 27 citationsModerate Sustained Virologic Response Rates With 6-Week Combination Directly Acting Anti–Hepatitis C Virus Therapy in Patients With Advanced Liver DiseaseSarah Kattakuzhy, Eleanor Wilson, Sreetha Sidharthan, Zayani Sims, Mary Ann McLaughlin
Clinical Infectious Diseases. 2015-10-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: